Comparative evaluation of the tolerability of cefazolin and nafcillin for treatment of methicillin-susceptible Staphylococcus aureus infections in the outpatient setting.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Nafcillin and cefazolin are considered first-line therapy for most infections with methicillin-susceptible Staphylococcus aureus (MSSA), and recent studies have suggested similar clinical efficacy. Limited data are available on the comparative tolerability of these agents.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Clin. Infect. Dis.

Title: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Publisher: Oxford University Press (OUP)

ISSN (Electronic): 1537-6591

ISSN (Print): 1058-4838

Publication date (Electronic): Aug 01 2014

Volume: 59

Issue: 3

Affiliations

[1 ] Division of Infectious Diseases, Massachusetts General Hospital Harvard Medical School Division of Infectious Diseases, Boston Children's Hospital.

[2 ] Division of Infectious Diseases, Massachusetts General Hospital Harvard Medical School Infection Control Unit, Massachusetts General Hospital, Boston, Massachusetts.

[3 ] Division of Infectious Diseases, Massachusetts General Hospital Harvard Medical School.

Article

Publisher Item ID: ciu301

DOI: 10.1093/cid/ciu301

PMC ID: 4110443

PubMed ID: 24785233

SO-VID: f0aae25d-1503-4e4b-9c77-7c58de5c1b63

History

Keywords: MSSA,OPAT,cefazolin,nafcillin,tolerability

Data availability:

Keywords: MSSA, OPAT, cefazolin, nafcillin, tolerability

Comments

Comment on this article

scite_

Cited by 26

See all cited by